About Global Summit on Molecular Genetics & Gene Therapy
Cenetri Publishing Group looks forward to welcome all the participants across the Globe to attend "International Conference on Molecular Genetics & Gene Therapy" during February 26-28, 2018 at Bangkok, Thailand. This conference offers contributors with the prospect to explore every aspect of Molecular Genetics & Gene Therapy to attendees. It is an exciting series of global speakers, lectures and workshops by expert sets featuring some of the world leading experts in the field. This summit is consisting of exceptional keynote sessions, poster presentations and oral talks of delegates attending the conference. Our revelation is to bring all the public who have interest to learn, share individuals who want to know novel methods for this problem and to inflate the experts of this field from the world.
ICMG-2018 Highlights:Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.Between 1989 and February 2016, over 2,300 clinical trials had been conducted, more than half of them in phase I.It should be noted that not all medical procedures that introduce alterations to a patient's genetic makeup can be considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients. Gene therapy is defined by the precision of the procedure and the intention of direct therapeutic effects.
Scope and Importance:Gene therapy involves the administration of a gene to treat a disease. Those treatments aim to be delivered only once or a few times rather than as a medicine administered long-term. Gene therapies could potentially cure a disease using methods such as adding a gene, correcting it, or using genetic material to cause cell death. That emerging market has attracted interest from pharma companies big and small, a trend likely to continue. Vision gain predicts expansion in gene therapy revenues from 2016 to 2026, building upon the extensive research and development in that biotechnological field. That medicine holds great promise for pharma companies and patients, the new study explains.
Scope of our analysis - the technologies whose potential you discover
In this report vision gain defines gene therapy as products modifying the expression of particular genes or correcting abnormal genes.
Therefore this study excludes some agents that may be considered as gene therapies under wider definitions, such as gene silencing and oligonucleotide therapies, antisense therapy and immune system stimulators.
Forecasts and other analyses showing opportunities in those genetic technologies Besides revenue forecasting to 2026, our analyses show results, growth rates and market shares. There you find original analysis. Our work also explains research and development. In that new report you gain 46 tables, 25 charts and three interviews. Now make your searching for data on gene therapies easier. Also save time and benefit your insight and authority. That way you can benefit your research, analysis and decisions, helping you see where progress and money lie. Stay ahead in knowledge. See what is possible for the therapeutic delivery of nucleic acid polymers into patients cells to treat diseases. The following sections show how visiongain's new investigation helps your work.
- North America
- Rest of the World
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Major Molecular Genetic & Gene Therapy Associations around the Globe
- Gene Therapy - American Medical Association
- Gene Therapy - The ALS Association
- Association for Molecular Pathology (AMP)
- Association for Clinical Genetic Science
- Association of Genetic Technologists
- American Association of Bio analysts - Molecular/Genetic Testing
- Molecular Biology Association Search Form - CGAP
- Pan-American Association for Biochemistry and Molecular Biology
- Molecular Biology Student Association - Home
- Funding in Research & Development
Cancer Gene Therapy Market size was USD 805.5 million in 2015, with 20.7% CAGR estimation from 2016 to 2024
Rapid technological advancements, increased adoption of emerging genomic technologies such as NGS and high density micro array are some of the factors that will drive global cancer gene therapy market over the forecast period. The rising prevalence of cancer is expected to increase the demand for gene therapy. In accordance with WHO, the number of new cases is projected to rise by 70% in next two decades The tremendous growth in number of patients should fuel the industry growth. Favourable government regulations will boost cancer genetics industry growth. For instance, Mainstreaming Cancer Genetics (MCG) programme aims to develop clinical infrastructure, assays, informatics, education and assessment that will allow gene testing of patients. The programme offers scalable and convenient tools for the integration of gene testing into mainstream medical practice across the NHS. High development cost of drugs will act as an impediment to industry growth. It's expensive to conduct clinical trials that includes expensive phase I, II and III for the approval. High cost of clinical trials will serve as a major bottleneck over the forecast time frame.
Why to attend Conference:This unique international conference provides a platform for researchers and decision makers in Molecular Genetics & Gene Therapy to present their latest findings and learn about all the important developments in Molecular Genetics & Gene Therapy. Many scientists and world's renowned experts will participate in the conference. Throughout the course of the Three days conference, you will have the opportunity to both network and hear leaders from the international academic and corporate Molecular Genetics & Gene Therapy communities. This conference seek to bring all such scientist, Noble Laureate, researcher, research scholar, students and people together who are involved in this field and provide them to discuss about their innovation, exchange ideas and interaction with each other.
Why Bangkok ?Bangkok rapid growth amidst little urban planning and regulation has resulted in a haphazard cityscape and inadequate infrastructure systems. The city has since turned to public transport in an attempt to solve this major problem. Four rapid transit lines are now in operation, with more systems under construction or planned by the national government and the Bangkok Metropolitan Administration.Bangkok welcomes more visitors than any other city in the world and it doesn't take long to realise why. Bangkok is a city of contrasts with action at every turn; marvel at the gleaming temples, catch a tuk tuk along the bustling Chinatown or take a long tail boat through floating markets. Food is another Bangkok highlight, from local dishes served at humble street stalls to haute cuisine at romantic rooftop restaurants.Luxury malls compete with a sea of boutiques and markets, where you can treat yourself without overspending. Extravagant Luxury hotels and surprisingly cheap serviced apartments welcome you with the same famed Thai hospitality. And no visit to Bangkok would be complete without a glimpse of its famous nightlife - from cabarets to exotic red-light districts, Bangkok never ceases to amaze.
Welcome to the "International Conference on Molecular Genetics & Gene Therapy" during February 26-28, 2018 at Bangkok, Thailand. The conference has the theme of "Promoting Basic and clinical knowledge, Awareness and education of Gene Therapy". This conference offers contributors with the prospect to explore every aspect of Molecular Genetics & Gene Therapy to attendees. Gene therapy involves the administration of a gene to treat a disease. Those treatments aim to be delivered only once or a few times rather than as a medicine administered long-term. Gene therapies could potentially cure a disease using methods such as adding a gene, correcting it, or using genetic material to cause cell death. That emerging market has attracted interest from pharma companies big and small, a trend likely to continue. Vision gain predicts expansion in gene therapy revenues from 2016 to 2026, building upon the extensive research and development in that biotechnological field. That medicine holds great promise for pharma companies and patients, the new study explains.
Bangkok welcomes more visitors than any other city in the world and it doesn't take long to realise why.
If you wish to share your data submit your research now.Looking forward to seeing you in Bangkok.
University of Hertfordshire
Mae Fah Luang University
Oswaldo Cruz Foundation (FIOCRUZ), Brazil
Molecular genetics is the field of biology and genetics that studies the structure and function of genes at a molecular level. The study of chromosomes and gene expression of an organism can give insight into heredity, genetic variation, and mutations. This is useful in the study of developmental biology and in understanding and treating genetic diseases. Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. Detailed scientific tracks can be found here.